News &
Announcements

Emerging Therapy Solutions CEO Ashley Hume joined other leaders from across the oncology community Sept. 15 at the Community Oncology Alliance Payer Exchange & Innovation Summit, an invite-only gathering focused on improving value, reducing costs and advancing quality in cancer care.

Ashley participated in a panel on Transformative Business Models for Delivering Cellular Therapy, exploring findings from COA’s Cellular Therapy Survey, barriers to access and evolving business models, including carve-out and partnership approaches that can help address financing and reimbursement challenges.

With decades of experience navigating high-cost and complex care, ETS brings an important perspective on what it takes to make access to emerging therapies more sustainable while supporting a positive patient experience.